rs6151627

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002439.5(MSH3):​c.580-380A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.227 in 152,126 control chromosomes in the GnomAD database, including 4,108 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.23 ( 4108 hom., cov: 32)

Consequence

MSH3
NM_002439.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.131

Publications

14 publications found
Variant links:
Genes affected
MSH3 (HGNC:7326): (mutS homolog 3) The protein encoded by this gene forms a heterodimer with MSH2 to form MutS beta, part of the post-replicative DNA mismatch repair system. MutS beta initiates mismatch repair by binding to a mismatch and then forming a complex with MutL alpha heterodimer. This gene contains a polymorphic 9 bp tandem repeat sequence in the first exon. The repeat is present 6 times in the reference genome sequence and 3-7 repeats have been reported. Defects in this gene are a cause of susceptibility to endometrial cancer. [provided by RefSeq, Mar 2011]
MSH3 Gene-Disease associations (from GenCC):
  • familial adenomatous polyposis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
  • MSH3-related attenuated familial adenomatous polyposis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Lynch syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002439.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.269 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002439.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH3
NM_002439.5
MANE Select
c.580-380A>G
intron
N/ANP_002430.3P20585

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH3
ENST00000265081.7
TSL:1 MANE Select
c.580-380A>G
intron
N/AENSP00000265081.6P20585
MSH3
ENST00000658259.1
c.412-380A>G
intron
N/AENSP00000499617.1A0A590UJW0
MSH3
ENST00000667069.1
c.580-380A>G
intron
N/AENSP00000499502.1A0A590UJN8

Frequencies

GnomAD3 genomes
AF:
0.227
AC:
34515
AN:
152008
Hom.:
4107
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.157
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.197
Gnomad ASJ
AF:
0.230
Gnomad EAS
AF:
0.257
Gnomad SAS
AF:
0.155
Gnomad FIN
AF:
0.268
Gnomad MID
AF:
0.242
Gnomad NFE
AF:
0.272
Gnomad OTH
AF:
0.241
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.227
AC:
34521
AN:
152126
Hom.:
4108
Cov.:
32
AF XY:
0.224
AC XY:
16675
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.157
AC:
6513
AN:
41506
American (AMR)
AF:
0.197
AC:
3013
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.230
AC:
799
AN:
3468
East Asian (EAS)
AF:
0.258
AC:
1332
AN:
5168
South Asian (SAS)
AF:
0.155
AC:
750
AN:
4828
European-Finnish (FIN)
AF:
0.268
AC:
2829
AN:
10554
Middle Eastern (MID)
AF:
0.236
AC:
69
AN:
292
European-Non Finnish (NFE)
AF:
0.272
AC:
18520
AN:
67992
Other (OTH)
AF:
0.239
AC:
506
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1379
2758
4138
5517
6896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.251
Hom.:
2462
Bravo
AF:
0.223
Asia WGS
AF:
0.191
AC:
663
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
3.7
DANN
Benign
0.89
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs6151627;
hg19: chr5-79965536;
COSMIC: COSV54147405;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.